COLLEGIUM PHARMACEUTICAL, INC (COLL) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for COLLEGIUM PHARMACEUTICAL, INC (COLL): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 63/100 — a percentile rank of COLLEGIUM PHARMACEUTICAL, INC’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $711.0M |
| P / E | 14.8× |
| P / S | 0.9× |
| EV / EBITDA | 4.3× |
| Gross margin | 74.7% |
| Operating margin | 19.6% |
| Net margin | 5.9% |
| Return on equity | 15.4% |
| ROIC | 7.7% |
| Revenue growth | 14.3% |
| Debt / equity | 3.5× |
| Dividend yield | 0.0% |
Is COLLEGIUM PHARMACEUTICAL, INC overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from COLLEGIUM PHARMACEUTICAL, INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact